Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis.

Pannone G, De Maria S, Zamparese R, Metafora S, Serpico R, Morelli F, Rubini C, Farina E, Carteni M, Staibano S, De Rosa G, Lo Muzio L, Bufo P.

Int J Oncol. 2007 Jun;30(6):1349-57.

PMID:
17487355
2.

Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.

Chen HH, Yu CH, Wang JT, Liu BY, Wang YP, Sun A, Tsai TC, Chiang CP.

Oral Oncol. 2007 Feb;43(2):122-9. Epub 2006 Jun 23.

PMID:
16798059
3.

Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.

Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.

Anticancer Res. 2009 Apr;29(4):1157-62.

4.

Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.

Kim HR, Christensen R, Park NH, Sapp P, Kang MK, Park NH.

Clin Cancer Res. 2001 Oct;7(10):3079-86.

5.

Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.

Lee BK, Diebel E, Neukam FW, Wiltfang J, Ries J.

Int J Oncol. 2001 Nov;19(5):1063-8.

PMID:
11605010
6.

Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.

Shibuya K, Fujisawa T, Hoshino H, Baba M, Saitoh Y, Iizasa T, Sekine Y, Suzuki M, Hiroshima K, Ohwada H.

Cancer. 2001 Aug 15;92(4):849-55.

PMID:
11550157
7.

Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR.

Cancer. 2002 Nov 15;95(10):2103-11.

8.

Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.

Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.

Arch Oral Biol. 2007 Nov;52(11):1079-87. Epub 2007 Jul 5.

PMID:
17612501
9.

Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.

Yu HP, Xu SQ, Lu WH, Li YY, Li F, Wang XL, Su YH.

J Surg Oncol. 2004 May 1;86(2):99-104.

PMID:
15112252
10.

Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.

Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG.

Braz Oral Res. 2011 Jan-Feb;25(1):34-41.

11.

Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.

Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH.

Acta Otolaryngol. 2005 Apr;125(4):409-14.

PMID:
15823813
12.

Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.

Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.

Head Neck. 2009 Aug;31(8):1039-48. doi: 10.1002/hed.21071.

PMID:
19340865
13.

Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis.

Luzar B, Poljak M, Marin IJ, Eberlinc A, Klopcic U, Gale N.

Histopathology. 2004 Jul;45(1):13-9.

PMID:
15228439
14.

Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma.

Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S, Hofele C.

J Oral Pathol Med. 2007 May;36(5):267-72.

PMID:
17448136
15.

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

Widschwendter A, Müller HM, Hubalek MM, Wiedemair A, Fiegl H, Goebel G, Mueller-Holzner E, Marth C, Widschwendter M.

Gynecol Oncol. 2004 May;93(2):407-16.

PMID:
15099954
16.

[Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].

Lu XZ, Yin XM, Feng YY, Duan LQ, Chen WT, Zhang CP.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jul;28(7):1165-7. Chinese.

17.

Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome.

Jiang Q, Pan HY, Ye DX, Zhang P, Zhong LP, Zhang ZY.

Tumour Biol. 2010 Oct;31(5):451-9. doi: 10.1007/s13277-010-0054-4. Epub 2010 Jun 8.

PMID:
20532727
18.

Human telomerase reverse transcriptase expression in oral carcinogenesis--a preliminary report.

Kumar SK, Zain RB, Ismail SM, Cheong SC.

J Exp Clin Cancer Res. 2005 Dec;24(4):639-46.

PMID:
16471328
19.

Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.

Imai Y, Sasaki T, Shinagawa Y, Akimoto K, Fujibayashi T.

Oral Oncol. 2002 Sep;38(6):557-61.

PMID:
12167433
20.

The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.

Wang X, Zhang J, Fan M, Zhou Q, Deng H, Aisharif MJ, Chen X.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Apr;107(4):547-54. doi: 10.1016/j.tripleo.2008.11.021.

PMID:
19327640
Items per page

Supplemental Content

Write to the Help Desk